Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Silexion Therapeutics (SLXN) CSO logs sale-to-cover share transaction
Shirvan Mitchell, CSO and CDO of Silexion Therapeutics (SLXN), reported selling 22,818 Ordinary Shares on March 26, 2026, at $1.36 per share. This transaction was a “sale-to-cover” to address tax liabilities from a fully vested restricted share unit grant received in February 2026. Following the sale, Mitchell directly holds 27,889 Ordinary Shares and an adjusted stock option for 478 Ordinary Shares.